EUCTR2016-003491-41-HU进行中（未招募）1 期
A Long Term Follow-up Study of AMG0001 in Subjects with Critical Limb Ischemia
AnGes Inc.0 个研究点目标入组 23 人开始时间: 2016年10月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 23
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Subjects who have been treated with AMG0001 in the AG-CLI-0206 study.
- •2. Subjects who have provided consent for the long term follow-up study either directly or through a legally authorized representative.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Subjects who were not enrolled in the AG-CLI-0206 study.
- •2. Subjects who enrolled in AG-CLI-0206 and who were not treated with AMG0001.
- •3. Subjects who have not provided consent for the long term follow-up study either directly or through a legally authorized representative.
研究者
相似试验
进行中（未招募）
1 期
Study to assess the long term safety of subjects who have been treated with AMG0001Critical limb ischemiaMedDRA version: 19.0Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866EUCTR2016-003491-41-BEAnGes Inc.23
进行中（未招募）
1 期
Study to assess the long term safety of subjects who have been treated with AMG0001Critical limb ischemiaMedDRA version: 20.0Level: LLTClassification code 10058069Term: Critical limb ischemiaSystem Organ Class: 100000004866EUCTR2016-003491-41-FRAnGes Inc.23
未知
3 期
A long-term extension study of AG-1749 in patients on concomitant long-term low-dose aspirin therapyPrevention of onset of low dose aspirin related gastric ulcerJPRN-jRCT2080220830Takeda Pharmaceutical Company Limited
未知
3 期
A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) usePrevention of ulcer associated with NSAIDsJPRN-jRCT2080220831Takeda Pharmaceutical Company Limited
进行中（未招募）
1 期
A Long-term Follow-up Study of Subjects With Malignancies Treated With CRISPR CAR Cellular TherapiesCTIS2024-512479-11-00CRISPR Therapeutics AG70